Buffett goes on “sales” and buys 4 pharmaceuticals
Warren Buffett CEO of Berkshire Hathaway considered one of the most successful investors in the world.
Warren Buffett and his team of investors unveiled their latest acquisitions on Monday, including four pharmaceutical companies: AbbVie (NYSE: ABBV), Merck, Bristol-Myers (NYSE: BMY) and Pfizer (NYSE: PFE). In the first three cases, it has revealed a similar investment close to 1.8 billion dollars, while, in the case of Pfizer, the investment was substantially lower, reaching 136 million.
The investment in these 4 members, however, is unrelated. Although Pfizer is now on everyone’s lips for its advances in the vaccine that could end the coronavirus pandemic, it has a very diversified business, the same as Merck, now focused on the development of cardiovascular drugs or focused on the female public. He is very dedicated to cancer, as is the case with Bristol Myers, which expanded its cancer treatment business with the purchase of Celgene (NASDAQ: CELG) last year. AbbVie, for its part, wants to branch out so as not to rely so heavily on Humira, its treatment for a number of inflammatory disorders. At the beginning of the year, it closed the acquisition of Allergan (NYSE: AGN), in the field of dermatology.
Of course, they remind us from The Motley Fool that, at the same time, these 4 companies do have something in common: the 4 are trading far from their all-time highs and have been this way throughout 2020, which suggests that Buffett would have taken the opportunity to go on “sales.”
On the contrary, it has reduced its positions in Barrick Gold (NYSE: GOLD), Costco (NASDAQ: COST) and also in some banks such as Wells Fargo (NYSE: WFC), JPMorgan (NYSE: JPM) or M&T Bank.
The stock market wants new stimuli since the real economy is bad European markets open weakly on Tuesday, a very Read more
Stock rally gains steam heading into the close, with the Dow jumping more than 450 points. Wall Street returns to Read more
Stanley Druckenmiller, one of the best traders of all time. We have 'borrowed' so much that the bags will not Read more
Stock markets are out of touch with reality and the bubble may burst. Throughout the month of August, the US Read more
"A collapse is coming," alerts Michael Gayed who has gained 60% with the crisis. His fund has gained 60% in Read more
The exchanges continue to mark historical highs as rumors are heard about the trade agreement with China, but the reality Read more
The company, specializing in voice technology and artificial intelligence, could become the second largest acquisition of the software giant Microsoft Read more
The stock rises 18% pending details of the venture capital proposal The shares of the Toshiba conglomerate - known for Read more
The situation will cause factories to stop and more costs. There will be manufacturers of technological devices that will launch fewer Read more
Europe's emissions trading has become a speculative market, where funds and investors want to make a killing. Just a year Read more